Dr. Marty Makary, former FDA Commissioner, explains the decision behind the FDA’s rollback of long-standing warnings on hormone replacement therapy. On Wall Street Week we look at the $360 billion women's health market, Wall Street's investment in menopause and the challenges of distinguishing evidence-based care from marketing hype https://bloom.bg/3EMZYZX ...

About one in nine Americans take a GLP-1 medication for weight loss, results from a new Gallup poll found—a staggering rise over the past two years as the obesity rate in the U.S. continues to decline from a record high in 2022.Read more: https://t.co/EqdLXp6BqWPhoto: Michael Siluk/UCG/Universal Images Group via Getty Images ...